Periodontal infection and dyslipidemia in type 2 diabetics: Association with increased HMG-CoA reductase expression

Hormone and Metabolic Research

Volumn 38, Issue 8, 2006, Pages 530-535

  Nishimura, F ^a   Taniguchi, A ^b   Yamaguchi Morimoto, M ^a   Soga, Y ^a   Iwamoto, Y ^a   Kokeguchi, S ^a   Kuroe, A ^b   Fukushima, M ^c   Nakai, Y ^d   Seino, Y ^b,e  

^a OKAYAMA UNIVERSITY   (Japan)

^b KANSAI DENRYOKU HOSPITAL   (Japan)

^c FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Diabetes; Dyslipidemia; HMG CoA reductase; Infection

Indexed keywords

CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; DYSLIPIDEMIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BACTEROIDACEAE INFECTIONS; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

BACTERIA (MICROORGANISMS); PORPHYROMONAS GINGIVALIS;

EID: 33748624341     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-949525     Document Type: Article

References (28)

1. Bierman EL. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb Vasc Biol 1992; 12: 647-656
2. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
3. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
4. Nelson RG, Shlossman M, Budding LM et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990; 13: 836-840
5. Taniguchi A, Nishimura F, Murayama Y et al. Porphyromonas gingivalis infection is associated with carotid atherosclerosis in non-obese Japanese type 2 diabetic patients. Metabolism 2003; 52: 142-145
6. DeStefano F, Anda RF, Kahn HS et al. Dental disease and risk of coronary heart disease and mortality. BMJ 1993; 306: 688-691
7. Saremi A, Nelson RG, Tulloch-Reid M et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005; 28: 27-32
8. Murayama Y, Nagai A, Okamura K et al. Serum immunoglobulin G antibody to periodontal bacteria. Adv Dent Res 1988; 2: 339-345
9. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454
10. Nishimura F, Taniguchi A, Iwamoto Y et al. Porphyromonas gingivalis infection is associated with elevated C-reactive protein in nonobese Japanese type 2 diabetic subjects. Diabetes Care 2002; 25: 1888
11. Slade GD, Ghezzi EM, Heiss et al. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 2003; 163: 1172-1179
12. Iwamoto Y, Nishimura F, Soga et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003; 74: 1231-1236
13. D'Aiuto F, Parkar M, Andreou G et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83: 156-160
14. Iwamoto Y, Nishimura F, Nakagawa M et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001; 72: 774-778
15. Uysal KT, Wiesbrock SM, Marino MW et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614
16. World Health Organization Diabetes Mellitus Report of a WHO Study Group. Geneva, World Health Org (Tech. Rep. Ser., no.727) 1985
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
18. Onoue S, Imai T, Kumada H et al. Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum. Microbiol Immunol 2003; 47: 51-55
19. Kato A, Ogasawara T, Homma T et al. Lipopolysaccharide-binding protein critically regulates lipopolysaccharide-induced IFN-beta signaling pathway in human monocytes. J Immunol 2004; 172: 6185-6194
20. Molvig J, Baek L, Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988; 27: 705-716
21. Liu S, Gallo DJ, Green AM et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 2002; 70: 3433-3442
22. Rattazzi M, Puato M, Faggin E et al. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens 2003; 21: 1787-1803
23. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001; 103: 1194-1197
24. Taskinen S, Kovanen PT, Jarva H et al. Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. Biochem J 2002; 367: 403-412
25. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987; 80: 184-190
26. Memon RA, Grunfeld C, Moser AH et al. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993; 132: 2246-2253
27. Jain A, Batista EL Jr, Serhan C et al. Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 2003; 71: 6012-6018
28. D'Aiuto F, Nibali L, Parker M et al. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005; 84: 269-273